XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 15, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2022
Allocated share-based compensation expense (reversal)   $ 90.5 $ 95.3 $ 168.5 $ 171.3  
Cost of revenue            
Allocated share-based compensation expense (reversal)   6.0 6.4 11.2 11.8  
Research and development            
Allocated share-based compensation expense (reversal) [1]   64.2 67.4 119.6 120.3  
Research and development | President            
Allocated share-based compensation expense (reversal) $ (6.7)         $ 4.4
Sales and marketing            
Allocated share-based compensation expense (reversal)   6.2 6.3 11.3 11.8  
General and administrative            
Allocated share-based compensation expense (reversal)   $ 14.1 $ 15.2 $ 26.4 $ 27.4  
[1] On March 15, 2023, the Company's former President resigned, resulting in the reversal of $6.7 million in stock-based compensation expense. Of the total amount reversed, $4.4 million related to expense recognized prior to January 1, 2023.